A 28-year-old married woman from rural Maharashtra attends the primary health centre for postpartum family planning counselling 6 weeks after a normal vaginal delivery. She has completed her family (2 children, both healthy). Her husband is supportive of contraception. She reports irregular menses before pregnancy and is concerned about hormonal side effects. On examination, she is haemodynamically stable with no contraindications to any method. What is the most appropriate first-line contraceptive method to counsel her about, considering epidemiological evidence of effectiveness and acceptability in the Indian context?

Explanation

## Postpartum Contraceptive Choice in Indian Context ### Clinical Context This woman is in the postpartum period (6 weeks), has completed her family, and has no medical contraindications. Irregular menses pre-pregnancy make hormonal methods less ideal for monitoring. ### Why Copper-T IUD is First-Line **Key Point:** The copper-T (Cu-T) intrauterine device is the gold standard long-acting reversible contraceptive (LARC) in India, with the highest continuation rates and effectiveness in real-world settings. **High-Yield:** Epidemiological data from Indian family planning programmes show: - **Effectiveness:** Pearl index 0.8–1.2 per 100 woman-years (99%+ effective) - **Continuation rate:** 70–80% at 5 years (highest among all reversible methods in India) - **Cost-effectiveness:** Single insertion, no user-dependent compliance - **No hormonal side effects:** Ideal for women concerned about hormonal effects - **Suitable in postpartum period:** Can be inserted immediately postpartum (within 48 hours) or at 6 weeks; 6-week insertion has lower expulsion rates **Clinical Pearl:** In Indian public health settings, IUD insertion at 6 weeks postpartum (rather than immediate postpartum) is preferred because expulsion rates are lower (2–5% vs. 10–15% with immediate insertion). ### Epidemiological Evidence | Method | Pearl Index (per 100 WY) | Continuation at 1 year (%) | User Dependency | |--------|--------------------------|----------------------------|------------------| | Copper-T IUD | 0.8–1.2 | 75–80 | None | | OCPs | 3–8 | 40–50 | High | | POP | 2–10 | 35–45 | High | | Barrier methods | 10–18 | 20–30 | Very high | **Mnemonic:** LARC > SARC — **Long-Acting Reversible Contraceptives (LARC)** outperform Short-Acting Reversible Contraceptives (SARC) in real-world effectiveness and acceptability in resource-limited settings. ### Why Not the Others? - **OCPs & POP:** Require daily compliance; irregular menses make monitoring difficult; higher discontinuation rates in rural India - **Barrier methods:** Low effectiveness in typical use; require consistent user compliance [cite:Park 26e Ch 6]